Max Solenthaler
Max Solenthaler publishes mostly in Hematology, Genetics and Immunology, on topics such as Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment and Acute Myeloid Leukemia Research.
- World rank
- #2,487,750 of 7,710,434 ranked researchers
- Rank in Switzerland
- #38,248 of 80,918
- Works
- 40
- Citations
- 3.8k
- Citations per work
- 95.7
What does Max Solenthaler research?
Max Solenthaler's work is mostly in Medicine (58%), Immunology and Microbiology (10%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2357.8%
- Medicine2357.8%
- Everything else1024.9%
- Life Sciences717.3%
- 1Hematology22% of their works
- 2Genetics21% of their works
- 3Immunology10% of their works
- 4Molecular Biology8% of their works
- 5Pathology and Forensic Medicine8% of their works
- 6Oncology7% of their works
Research topics
Which keywords describe Max Solenthaler's research?
The keywords of their largest research topics: Rituximab, Prognostic Factors, Chronic Lymphocytic Leukemia, Genomic Aberrations, Classification, Lymphoma, Acute Myeloid Leukemia and AML.
- Retinoic Acid
- Thalassemia
- Immune
- Blood Groups
- Imatinib
- Acute Myeloid Leukemia
- Lymphoma
- Genomic Aberrations
- Prognostic Factors
- Rituximab
- Chronic Lymphocytic Leukemia
- Classification
- AML
- BCR-ABL
- Alloimmunization
- Complement
- Sickle-cell Disease
- Acute Promyelocytic Leukemia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Rituximab252 topics
- Prognostic Factors222 topics
- Chronic Lymphocytic Leukemia161 topic
- Genomic Aberrations161 topic
- Classification91 topic
- Lymphoma91 topic
- AML61 topic
- Acute Myeloid Leukemia61 topic
- BCR-ABL51 topic
- Imatinib51 topic
- Alloimmunization41 topic
- Blood Groups41 topic
- Complement41 topic
- Immune41 topic
- Sickle-cell Disease41 topic
- Thalassemia41 topic
- Acute Promyelocytic Leukemia31 topic
- Retinoic Acid31 topic
Where does Max Solenthaler work?
Max Solenthaler's main affiliation in the publication record is University Hospital of Bern, Switzerland.
How many publications and citations does Max Solenthaler have?
OpenAlex counts 40 works and 3,829 citations for Max Solenthaler, an h-index of 17, ranking #2,487,750 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Max Solenthaler. Posts are plain text and can be reported.